Multiple immunosuppressive therapies increase infection risks for cancer patients
Retrospective analysis of more than 20,000 patient records identifies opportunities for risk-mitigating approaches in certain patient populations.
Read original article on The Medical News →Related news
-
Intuitive eating may be linked to more than a healthier relationship with food
-
Neuromedin U drives immune suppression in aggressive prostate cancer
-
Scientists gave worms magnetic bacteria. They lived 43% longer
-
Why are more younger adults in the Eastern Mediterranean facing colorectal cancer?
-
USP15 enzyme emerges as potential target for ovarian cancer treatment
-
Uterus transplantation shows improving outcomes and successful births nationwide
-
The heart effects of antidepressants may depend as much on the patient as the drug
-
AI model predicts immunotherapy-related pneumonitis risk from CT scans